Pope W - Search Results

1

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC. Albert NL, et al. Among authors: pope w. Neuro Oncol. 2016 Sep;18(9):1199-208. doi: 10.1093/neuonc/now058. Epub 2016 Apr 21. Neuro Oncol. 2016. PMID: 27106405 Free PMC article. Review.

2

MR imaging correlates of survival in patients with high-grade gliomas.

Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF. Pope WB, et al. AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2466-74. AJNR Am J Neuroradiol. 2005. PMID: 16286386 Free PMC article.

3

18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.

Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T. Chen W, et al. Among authors: pope w. J Nucl Med. 2006 Jun;47(6):904-11. J Nucl Med. 2006. PMID: 16741298 Free article. Clinical Trial.

4

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.

Chen W, Delaloye S, Silverman DH, Geist C, Czernin J, Sayre J, Satyamurthy N, Pope W, Lai A, Phelps ME, Cloughesy T. Chen W, et al. Among authors: pope w. J Clin Oncol. 2007 Oct 20;25(30):4714-21. doi: 10.1200/JCO.2006.10.5825. J Clin Oncol. 2007. PMID: 17947718

5

Time course of imaging changes of GBM during extended bevacizumab treatment.

Ananthnarayan S, Bahng J, Roring J, Nghiemphu P, Lai A, Cloughesy T, Pope WB. Ananthnarayan S, et al. J Neurooncol. 2008 Jul;88(3):339-47. doi: 10.1007/s11060-008-9573-x. Epub 2008 Apr 4. J Neurooncol. 2008. PMID: 18389177

6

Safety of anticoagulation use and bevacizumab in patients with glioma.

Nghiemphu PL, Green RM, Pope WB, Lai A, Cloughesy TF. Nghiemphu PL, et al. Neuro Oncol. 2008 Jun;10(3):355-60. doi: 10.1215/15228517-2008-009. Epub 2008 Apr 24. Neuro Oncol. 2008. PMID: 18436627 Free PMC article.

7

18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.

Ledezma CJ, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J, Pope W. Ledezma CJ, et al. Among authors: pope w. Eur J Radiol. 2009 Aug;71(2):242-8. doi: 10.1016/j.ejrad.2008.04.018. Epub 2008 May 29. Eur J Radiol. 2009. PMID: 18511228

8

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone.

Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB. Kappadakunnel M, et al. J Neurooncol. 2010 Feb;96(3):359-67. doi: 10.1007/s11060-009-9983-4. Epub 2009 Aug 5. J Neurooncol. 2010. PMID: 19655089 Free PMC article.

9

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab.

Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB. Ellingson BM, et al. Neuro Oncol. 2011 Apr;13(4):401-9. doi: 10.1093/neuonc/noq206. Epub 2011 Feb 15. Neuro Oncol. 2011. PMID: 21324937 Free PMC article.

10

Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab.

Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB. Ellingson BM, et al. J Neurooncol. 2011 Oct;105(1):91-101. doi: 10.1007/s11060-011-0567-8. Epub 2011 Mar 26. J Neurooncol. 2011. PMID: 21442275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters